Evidence map›Paper›PMID 41805155›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2026

COPD Exacerbation Recognition Tool: Translation, Linguistic, and Cross-Cultural Validation.

Rainer Gloeckl, Ruth Tal-Singer, Peter Deussen, Russell Winwood, Tharishini Mohan, Megan Turner, Mohamed Hamouda, Mandeep Moore, Paul Jones

Abstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rainer GloecklInstitute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany
Ruth Tal-SingerGlobal Allergy and Airways Patient Platform, Vienna, Austria
Peter DeussenBiomedical Research Group Oxford (PPI), Oxford, United Kingdom
Russell WinwoodInogen Global, Zurich, Switzerland
Tharishini MohanGlobal Medical Affairs, General Medicines, GSK, London, United Kingdom
Megan TurnerGlobal Clinical Operations Research and Development, GSK, Collegeville, Pennsylvania, United States
Mohamed HamoudaValue Evidence and Outcomes Research, GSK, Dubai, United Arab Emirates
Mandeep MooreGlobal Medical Affairs, General Medicines, GSK, London, United Kingdom
Paul JonesAdvanced Pipeline Unit Respiratory, GSK, London, United Kingdom

Funding

GlaxoSmithKline 222091
6 · The paper itself

Abstract

Background: The Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Recognition Tool (CERT) was developed to improve patients’ recognition of COPD exacerbations. This validation study concerned the cross-cultural and linguistic validation of 46 CERT translations across 25 countries and 6 continents. Methods: This study employed a rigorous, certified (International Organization for Standardization-17100) methodology. Dual forward translations for each language were developed by independent translators who were native speakers of the target language and then reconciled by a linguistic validation consultant (LVC). Independent linguists provided a back translation of the reconciled translation, which was reviewed by the LVC and project manager. Linguistic validation was performed for each language through cognitive debriefing interviews with at least 5 participants with COPD who were native speakers of the target language. These participants also reviewed 7 sets of images produced for different global regions to reflect patients from a diversity of cultures, countries, and religions, to determine if the images were representative of themselves and/or other people living with COPD. The images were amended as needed and reshown to the participants for approval. Results: The translations were found to be conceptually equivalent to the original CERT and harmonized with each other. Participants found the CERT easy to use and understand and confirmed that the images were representative of themselves and/or other people living with COPD. Conclusion: CERT translations were created using a patient-centric approach and appear to be easily understandable and valid across many languages and cultures.

Indexed as

COPDeducationexacerbationpatient-centered

Identifiers

PMID41805155
PMCPMC13165497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.